Ginkgo Bioworks is a pioneer in the synthetic biology space, building “made-to-order” microbes that can be used to help with everything from climate change to the pandemic response. This deal values the company at $15B, reportedly making it one of the largest SPAC mergers ever.
Lusha aims to hire about 20 people in Boston over the next several months, and sees this new office as a “crucial” step toward its goal of becoming the largest data-sharing tool for B2B sales.
Mirakl says it will use this fresh funding, in part, to hire hundreds of new people across its sales, customer success and engineering departments, 250 of which will be based out of its Boston HQ.
Crayon aims to make the competitive intelligence process more “programmatic, cheap and timely,” providing insights that help major companies like Dropbox and Salesforce make business decisions more confidently.
